Oncology
Immuno Oncology
Anti-Virus
Disease Modeling
Cosmetics
Toxicity
Spatial Biology
Technology Service
Cancer Organoid
Research Service
Others
Price | 4929€+ Login to see price |
Organism | Human |
Product Type | Organoid |
Tissue | PSC, Lung tissue |
Disease | – |
Applications
Toxicity
Organoid Based
Anti-Virus
Influenza Virus
Adenovirus
Disease Modeling
Respiratory and ENT Disease
At the forefront of stem cell innovation, we specialize in creating lung organoids using both tissue samples and induced pluripotent stem cells (iPSCs).
Our cutting-edge methods enable us to induce lung differentiation from iPSCs, resulting in highly accurate and functional lung organoids.
These organoids are applicable in a wide range of experimental research and therapeutic development.
Our lung organoids closely mimic the key structural features of human lung tissue.
Replicating the morphology of actual lung tissue, including critical structures like alveoli.
Composed of various cell types, including type I and II alveolar epithelial cells, ciliated cells, and secretory cells, accurately reflecting the functional complexity of real lung tissue.
Our lung organoids are created using induced pluripotent stem cells (iPSCs) and exhibit key structural and cellular characteristics of human lungs.
These organoids can be infected with the influenza virus, making them ideal for studying infection mechanisms and therapeutic interventions.
Our lung organoid fibrosis model is developed using induced pluripotent stem cells (iPSCs) that are differentiated into lung tissue.
These organoids exhibit key features of human lung tissue and can be induced to develop fibrotic characteristics, providing a realistic and detailed model for studying pulmonary fibrosis.
@ 2024 . All rights reserved
@ 2024 . All rights reserved